# The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients

> **NCT06604247** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 18 (actual)

## Conditions studied

- Breast Cancer
- Prostate Cancer

## Interventions

- **BEHAVIORAL:** Cognitive Behavioral therapy for insomnia (CBT-I)

## Key facts

- **NCT ID:** NCT06604247
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-30
- **Primary completion:** 2023-10-01
- **Final completion:** 2024-06-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06604247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06604247, "The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06604247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*